Cargando…
Estimating and reporting treatment effects in clinical trials for weight management: using estimands to interpret effects of intercurrent events and missing data
In the approval process for new weight management therapies, regulators typically require estimates of effect size. Usually, as with other drug evaluations, the placebo-adjusted treatment effect (i.e., the difference between weight losses with pharmacotherapy and placebo, when given as an adjunct to...
Autores principales: | Wharton, Sean, Astrup, Arne, Endahl, Lars, Lean, Michael E. J., Satylganova, Altynai, Skovgaard, Dorthe, Wadden, Thomas A., Wilding, John P. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081661/ https://www.ncbi.nlm.nih.gov/pubmed/33462358 http://dx.doi.org/10.1038/s41366-020-00733-x |
Ejemplares similares
-
Rethinking intercurrent events in defining estimands for tuberculosis trials
por: Pham, Tra My, et al.
Publicado: (2022) -
Translating questions to estimands in randomized clinical trials with intercurrent events
por: Stensrud, Mats J., et al.
Publicado: (2022) -
Handling intercurrent events and missing data in non-inferiority trials using the estimand framework: A tuberculosis case study
por: Rehal, Sunita, et al.
Publicado: (2023) -
PNS250 How to Deal with COVID-19-Related Intercurrent Events on Trial Estimands for Patient-Reported Outcomes (PRO) Objectives
por: Skaltsa, K., et al.
Publicado: (2020) -
MON-120 Effect of Weight Loss on Physical Function Measured by the 6-Minute Walking Distance Test in Individuals with Obesity: Results from the SCALE IBT Trial of Liraglutide 3.0 Mg
por: Rubino, Domenica, et al.
Publicado: (2019)